Kopen Pt 141 Bremelanotide Peptide

Sourcing (kopen) PT-141 Bremelanotide for analytical or laboratory research requires verified structural integrity and strict purity standards. PT-141 is a synthetic cyclic heptapeptide melanocortin receptor agonist widely investigated in preclinical models for its role in central nervous system signaling pathways linked to sexual-health physiology.

GMP-compliant U.S. facilities
ISO 17025 third-party COAs
100% domestic — no imports
Fast tracked domestic shipping
Shop research peptides

Quick answer

Sourcing (kopen) PT-141 Bremelanotide for analytical or laboratory research requires verified structural integrity and strict purity standards. PT-141 is a synthetic cyclic heptapeptide melanocortin receptor agonist widely investigated in preclinical models for its role in central nervous system signaling pathways linked to sexual-health physiology.

Reviewed by PX1 Research scientific team

Key takeaways

  • When purchasing or acquiring (kopen) high-purity [PT-141 Bremelanotide](/product/pt-141-bremelanotide) for experimental applications, principal investigators and laboratory technicians must prioritize analytical validation over basic commercial availability.
  • [PT-141](/research-peptides/pt-141) Bremelanotide is a cyclic heptapeptide with the chemical formula C50H68N14O10 and a molecular weight of approximately 1025.2 g/mol.
  • Preclinical literature demonstrates that [PT-141](/research-peptides/pt-141) functions primarily as a potent agonist at melanocortin receptors, displaying specific affinity for the MC3R and MC4R subtypes within the central nervous system.
  • In vivo rodent models have established [PT-141](/research-peptides/pt-141) as a crucial tool for investigating central mechanisms underlying reproductive behavior and neuroendocrine function.

Sourcing Reference-Grade PT-141 Bremelanotide for Research

When purchasing or acquiring (kopen) high-purity PT-141 Bremelanotide for experimental applications, principal investigators and laboratory technicians must prioritize analytical validation over basic commercial availability. As a synthetic derivative of Melanotan II, PT-141 exhibits a targeted binding affinity for specific melanocortin receptor subtypes without the potent melanocyte-stimulating properties observed in earlier analogs.

To maintain assay reproducibility across cellular and rodent models, research facilities must source material verified via high-performance liquid chromatography (HPLC) and mass spectrometry (MS). PX1 Research provides fully traceably synthesized PT-141 for non-clinical research environments, ensuring each batch meets rigorous standards for purity, sequence identity, and bioburden controls.

Chemical Structure and Molecular Characteristics of PT-141

PT-141 Bremelanotide is a cyclic heptapeptide with the chemical formula C50H68N14O10 and a molecular weight of approximately 1025.2 g/mol. Derived structurally from the endogenous alpha-melanocyte-stimulating hormone (α-MSH), its sequence features a lactam bridge formed between the side chains of Lysine and Aspartic Acid. This conformational constraint significantly enhances enzymatic stability against serum proteases compared to linear peptides.

In analytical evaluations, the cyclic core of PT-141 provides structural rigidity that governs its binding thermodynamics with transmembrane G-protein coupled receptors (GPCRs). Researchers evaluating this compound in physical chemistry or structural biology assays rely on high-purity solid-phase peptide synthesis (SPPS) products to prevent truncated impurities or uncyclized side-products from skewing binding affinity measurements.

Mechanism of Action: Melanocortin Receptor Agonism

Preclinical literature demonstrates that PT-141 functions primarily as a potent agonist at melanocortin receptors, displaying specific affinity for the MC3R and MC4R subtypes within the central nervous system. Unlike peripheral vasoactive agents, PT-141 acts via neurogenic pathways within the hypothalamus, modulating downstream autonomic and behavioral pathways.

In vitro functional assays show that binding of PT-141 to central MC4R activates adenylate cyclase, resulting in an intracellular accumulation of cyclic adenosine monophosphate (cAMP). This signal transduction cascade triggers downstream release of oxytocin and dopamine in brain regions such as the medial preoptic area (mPOA) and the nucleus accumbens, key regions implicated in motivational and physiological responses.

Preclinical Literature: Investigating Sexual-Health Pathways

In vivo rodent models have established PT-141 as a crucial tool for investigating central mechanisms underlying reproductive behavior and neuroendocrine function. Studies involving male and female rodent models indicate that central or systemic administration of PT-141 induces appetite, pro-erectile, and appetitive motivational behaviors independently of peripheral vascular dilation or direct nitric oxide synthase upregulation.

Furthermore, comparative research within the broader melanocortin receptor agonists catalog highlights the unique divergence of PT-141 from skin-pigmentation pathways. Because PT-141 lacks high-affinity activation of MC1R relative to Melanotan II, researchers frequently utilize it as a selective probe to isolate central neuroendocrine pathways without confounding melanogenic responses in skin tissue cultures.

Comparative Analysis: PT-141 vs. Related Neuroendocrine Agonists

To properly contextualize PT-141 within neuroendocrine research, investigators frequently compare its receptor binding profile and downstream physiological markers against other hypothalamic and reproductive pathway peptides. The table below outlines key distinctions between PT-141 and related research compounds in preclinical investigation:

While Melanotan II shares structural lineage with PT-141, MT-2 displays non-selective agonism across MC1R, MC3R, MC4R, and MC5R, making it less suitable for isolated CNS melanocortin receptor mapping. Conversely, non-melanocortin peptides like Kisspeptin-10 act upstream on the GPR54 receptor to modulate the hypothalamic-pituitary-gonadal (HPG) axis, and Oxytocin regulates neuropeptide signaling through distinct oxytocinergic pathways. Reviewing the PX1 Research Hub offers further documentation on categorizing these distinct signaling cascades.

Reconstitution Protocols and In Vitro Solution Handling

Proper reconstitution of lyophilized PT-141 Bremelanotide is vital for preserving secondary structure and preventing aggregation. Laboratories acquiring PT-141 should perform handling inside a certified laminar flow hood utilizing sterile, ice-cold Bacteriostatic Water or sterile 0.9% Sodium Chloride injection grade solution depending on the specific cell culture or assay buffer compatibility.

To reconstitute, introduce the diluent slowly along the internal glass wall of the vial rather than spraying directly onto the lyophilized cake. Gentle agitation or slow inversion should be used until full dissolution occurs; mechanical vortexing must be strictly avoided as shear forces can disrupt the cyclic peptide conformation. Detailed parameters for volume calculations and diluent selection can be reviewed in our comprehensive peptide reconstitution guide.

Laboratory Storage, Stability, and Aliquoting Guidelines

Lyophilized PT-141 Bremelanotide should be stored at -20°C upon receipt for long-term stability, shielded from light exposure. Under these conditions, the desiccated powder maintains chemical integrity for extended periods. Avoid repeated freeze-thaw cycles by aliquoting reconstituted stock solutions into single-use microcentrifuge tubes.

Once reconstituted into aqueous solution, aliquots stored at 2°C to 8°C should generally be utilized within 14 to 30 days depending on the preservative used (e.g., benzyl alcohol in bacteriostatic water). For long-term storage of liquid stock solutions, freezing at -80°C is recommended. Investigators should monitor liquid solutions for turbidity or precipitation prior to introducing the reagent into automated pipetting systems or cell culture media.

Supplier Quality Verification: HPLC, MS, and Endotoxin Standards

Researchers tasked with procuring (kopen) PT-141 Bremelanotide must evaluate prospective suppliers against rigorous analytical metrics. Low-grade peptides often contain residual trifluoroacetic acid (TFA) salts, truncated synthesis sequences, or bacterial endotoxins that can contaminate sensitive cell culture assays or skew receptor binding kinetics.

PX1 Research ensures total quality assurance by verifying every batch through an independent, ISO 17025 accredited laboratory. Each batch is accompanied by a public, downloadable Certificate of Analysis (COA) detailing reverse-phase HPLC purity (guaranteed >99%), electrospray ionization mass spectrometry (ESI-MS) for exact molecular mass confirmation, and chromogenic LAL assays verifying endotoxin levels below <0.5 EU/mg.

Procurement Protocols for Research Institutions

Acquiring analytical reagents for academic, industrial, or government laboratory facilities requires transparent vendor compliance and rapid fulfillment logistics. PX1 Research manufactures all compounds in GMP-compliant facilities within the United States, maintaining strict inventory controls and lot traceability from raw amino acid coupling through final lyophilization.

For high-throughput screening projects or long-term clinical trial models, research facilities can explore bulk order structures via our dedicated wholesale laboratory accounts. Orders are processed immediately and shipped directly from our California and Arizona logistics hubs with same-day dispatch for orders placed before standard daily cutoffs.

Frequently Asked Questions

What does 'kopen' mean in the context of sourcing PT-141 Bremelanotide?

'Kopen' translates to 'buy' or 'procure' in several European languages (such as Dutch). In a scientific context, it refers to acquiring high-purity, reference-standard PT-141 Bremelanotide for accredited laboratory research use.

What is the primary mechanism of action of PT-141 Bremelanotide?

PT-141 acts primarily as a central melanocortin receptor agonist, exhibiting high selectivity for the MC3R and MC4R receptor subtypes in the central nervous system to modulate neuroendocrine and motivational signaling pathways.

How does PT-141 differ from Melanotan II in preclinical research?

While both are cyclic melanocortin agonists, PT-141 is a metabolite derivative of Melanotan II that lacks significant affinity for the MC1R receptor. Consequently, PT-141 does not induce significant melanogenesis (skin pigmentation), making it ideal for isolating neuroendocrine pathways.

What analytical tests are provided with PX1 Research PT-141?

Every lot of PT-141 from PX1 Research includes a lot-specific Certificate of Analysis featuring RP-HPLC (purity >99%), Mass Spectrometry (molecular weight confirmation), and LAL endotoxin testing (<0.5 EU/mg).

How should lyophilized PT-141 be stored upon delivery?

Lyophilized PT-141 should be stored at -20°C in a dry, dark environment upon arrival. Proper storage prevents degradation and hydrolysis over extended periods.

Which diluent is recommended for reconstituting PT-141 for laboratory assays?

Bacteriostatic Water (0.9% benzyl alcohol) or sterile 0.9% Sodium Chloride solution is typically recommended, depending on downstream assay protocols and cellular toxicity limits.

Can PT-141 Bremelanotide be purchased for human consumption?

No. PT-141 Bremelanotide supplied by PX1 Research is strictly designated for laboratory research, in vitro assays, and preclinical animal models. It is not for human or clinical use.

Where does PX1 Research ship its research peptides from?

PX1 Research synthesizes and packages peptides in USA-based, GMP-compliant facilities and ships directly from dispatch centers located in California and Arizona.

Related pages

All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.